A company with well-publicized patent expirations priced into its stock, like Bristol Myers Squibb facing the Revlimid cliff in 2023, offers a different investment proposition than a company whose patent exposure is poorly understood
Mechanistic data suggest that environmental pollutants may influence IBD risk and outcomes through microbial dysbiosis and intestinal barrier disruption, ultimately leading to intestinal inflammation
In particular, resistance training, especially strength training, has been shown to be effective in preserving and increasing muscle mass
What they found: Cagrilintide 4.5 mg: 10.8 % weight reduction vs 3.0 % placebo (p 40 % of patients achieved 25 % weight reduction , historically unprecedented Safety profile in line with Phase 2 data Why it matters: REDEFINE 1 confirmed CagriSema as the largest body-weight signal reported in the published incretin literature to date
Sterility: Maintain a sterile environment when preparing and administering injections
Talk to a doctor who understands metabolic health and the GLP-1 drug class